OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
March 07, 2023
Vibeke Strand, MD, MACR, FACP, shares the advantages and limitations of the AIMS and comparative cohort studies in the treatment of RA.
An expert rheumatologist discusses the Accelerate Information of Molecular Signatures (AIMS) study and the comparative cohort study of the MSRC test.
Vibeke Strand, MD, MACR, FACP, reviews the tools available to clinicians to improve treatment selection in RA, focusing on the molecular signature response classifier test.
February 28, 2023
Dr Vibeke Strand highlights the use of tumor necrosis factor inhibitors in the treatment of RA.